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 Active Bacterial Core Surveillance (ABCs) Report 
Emerging Infections Program Network 
Neisseria meningitidis, 2006
ABCs Areas 
California (3 county San Francisco Bay area); 
Colorado (5 county Denver area); Connecticut; 
Georgia; Maryland; Minnesota; New Mexico; New 
York (15 county Rochester and Albany areas); 
Oregon; Tennessee (11 urban counties) 
 
ABCs Population 
The surveillance areas represent 39,979,545 persons. 
Source: National Center for Health Statistics 
bridged-race vintage 2006 postcensal file 
 
ABCs Case Definition 
Invasive meningococcal disease: isolation of Neisseria 
meningitidis from normally sterile site in a resident of 
a surveillance area in 2006.  
 
ABCs Methodology 
ABCs personnel routinely contacted all microbiology 
laboratories serving acute care hospitals in their area to 
identify cases. Standardized case report forms that 
include information on demographic characteristics, 
clinical syndrome, and outcome of illness were 
completed for each identified case.  Serogrouping of 
meningococcal isolates was done at CDC.  Regular 
laboratory audits assessed completeness of active 
surveillance and detected additional cases.  
 
All rates of  invasive meningococcal disease were 
calculated using population estimates for 2006. For 
national estimates of cases, race- and age-specific rates 
of disease were applied from the aggregate 
surveillance area to the age and racial distribution of 
the 2006 U.S. population for 49 states (excluding 
Oregon due to an outbreak of serogroup B disease). 
The Oregon reported cases were then added to obtain 
the national estimates. Cases with unknown race were 
distributed by area based on reported race distribution 
for known cases within the eight age categories. 
 
Reported ABCs Profiles 
Race             No.    (Rate*)
White 111 (0.36) 
Black 28 (0.41) 
Other 6 (0.24) 
Total 145 (0.36) 
 
Unknown race (n=19) distributed amongst known 
* Cases per 100,000 population for ABCs areas 
 
 
 Cases Deaths 
Syndrome      No.  (%*) No. (Rate†)
Meningitis 67   (46.2) 12   (17.9) 
Bacteremia without focus 55   (37.9) 3   (5.6) 
 
* Percent of cases 
† Deaths per 100 cases with known outcomes 
 
 Serogroups  
Age B C Y Other‡ 
 (years)    No.  (Rate*)  No.  (Rate*)   No. (Rate*)  No. (Rate*)
< 1 13   (2.6) 0   (0.0)     3    (0.61)    0   (0.0) 
1  0   (0.0)  0   (0.0)     0    (0.0) 1   (0.2) 
2-4 2   (0.13) 0   (0.0)     0    (0.0) 1   (0.07) 
5-17 1   (0.02) 8   (0.12)     7    (0.11)   0 (0.0) 
18-34 8   (0.09) 11   (0.13)     7    (0.08)    0 (0.0) 
35-49 3   (0.04) 8   (0.10)     2    (0.02)    0 (0.0) 
50-64   1   (0.02) 2   (0.03)    10    (0.16)    1 (0.02) 
≥ 65  2   (0.05) 0   (0.00)    13    (0.32)    4 (0.09) 
Total † 30   (0.08) 29   (0.08)    42    (0.12)   7 (0.02) 
 
Unknown serogroup (n=6) distributed amongst known 
*Cases per 100,000 population for ABCs areas excluding Oregon 
† All rates exclude Oregon;  Rates including Oregon are    
serogroup B 0.11, serogroup C 0.09, serogroup Y 0.14, and 
serogroup Other 0.04 cases per 100,000 population for ABCs areas
‡ Other includes serogroup W-135 and non-groupables 
 
 
Rates of Meningococcal Disease in Adolescents 
and Young Adults† 
 
Overall 
Serogroups 
C/Y/W-135 
Serogroups 
Age (years)        No.  (Rate*)       No.  (Rate*)
11-17 14 (0.39) 13 (0.37) 
18-22 13   (0.52)  6 (0.24)  
 
* Cases per 100,000 population for ABCs areas excluding Oregon 
† All rates exclude Oregon;  Rates including Oregon are, for 11-17 
year olds, overall serogroups  0.38 and serogroup C/Y/W-135 0.33, 
for 18-22 year olds, overall serogroups 0.73 and serogroup C/Y/W-
135 0.40 cases per 100,000 population for ABCs areas 
 
National Estimates for Invasive Disease 
 Cases:      900  (0.30/100,000)    
 Deaths:    125  (0.04/100,000) 
 
 
Healthy People 2010 Update 
Objective: Reduce the incidence of invasive 
meningococcal disease to 1.0 per 100,000 population. 
2010 Objective 2006 Rate*  
1.0/100,000     0.30/100,000  
 
* Cases per 100,000 U.S. population  
 
For more information, visit our web site: 
 http://www.cdc.gov/abcs  
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